Yiyang Pharmaceutical Co., Ltd.
GPTKB entity
Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
local pharmaceutical companies
|
| gptkbp:awards |
gptkb:National_Quality_Award
|
| gptkbp:capacity |
high capacity production
|
| gptkbp:CEO |
gptkb:Zhang_Jian
|
| gptkbp:certifications |
GMP
|
| gptkbp:clinicalTrials |
ongoing
|
| gptkbp:collaborations |
universities
research institutes |
| gptkbp:community_involvement |
education programs
environmental sustainability projects healthcare_initiatives |
| gptkbp:employees |
over 3,000
|
| gptkbp:exportMarkets |
gptkb:North_America
gptkb:Southeast_Asia Africa Europe |
| gptkbp:financialPerformance |
consistent growth
|
| gptkbp:focus |
research and development
|
| gptkbp:founded |
1992
|
| gptkbp:future_plans |
increased production capacity
expansion into new markets development of new drugs |
| gptkbp:headquarters |
gptkb:Yiyang,_Hunan,_China
|
| https://www.w3.org/2000/01/rdf-schema#label |
Yiyang Pharmaceutical Co., Ltd.
|
| gptkbp:industry |
healthcare
|
| gptkbp:investmentFocus |
infrastructure development
technology upgrades R&D investments |
| gptkbp:market |
gptkb:China
top 100 pharmaceutical companies in China leading_pharmaceutical_company_in_Hunan |
| gptkbp:partnerships |
various international pharmaceutical companies
|
| gptkbp:patentCitation |
numerous patents in pharmaceuticals
|
| gptkbp:productionLocation |
state-of-the-art facilities
|
| gptkbp:products |
tablets
capsules injectables medicines oral solutions |
| gptkbp:research_focus |
oncology
antibiotics cardiovascular drugs CNS drugs |
| gptkbp:revenue |
over 1 billion RMB
|
| gptkbp:stockExchange |
002603
|
| gptkbp:subsidiary |
gptkb:Hunan_Yiyang_Pharmaceutical_Co.,_Ltd.
|
| gptkbp:supplyChain |
integrated supply chain management
|
| gptkbp:sustainability_initiatives |
energy efficiency measures
waste reduction initiatives green manufacturing processes |
| gptkbp:type |
public company
|
| gptkbp:website |
www.yiyangpharma.com
|